Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael J Schell

Showing results (11-20 of 156) with videos related to

Pageof 16
Sort By:
Biometrics|July 14, 2005
Continuous toxicity monitoring in phase II trials in oncologyAnastasia Ivanova, Bahjat F Qaqish, Michael J Schell
The Biochemical Journal|June 29, 2005
Agonist-induced regulation of mitochondrial and endoplasmic reticulum motilityDavid Brough, Michael J Schell, Robin F Irvine
JAMA|October 11, 2022
Physician Adenoma Detection Rates and Colorectal CancerMichael J Schell, Clement K Gwede, Mark Friedman
JAMA Network Open|March 10, 2020
Assessment of Treatment Cost-effectiveness Using a Colorectal Cancer Mutation ProfileTimothy J Yeatman, Michael J Schell, William Sause
Plos One|October 22, 2009
Analysis of group randomized trials with multiple binary endpoints and small number of groupsJi-Hyun Lee, Michael J Schell, Richard Roetzheim
Cancer Control : Journal of the Moffitt Cancer Center|December 17, 2009
The false discovery rate: a key concept in large-scale genetic studiesJames J Chen, Paula K Roberson, Michael J Schell
Biorxiv : the Preprint Server for Biology|May 18, 2026
Synthetic Data Generation and Nonparametric Techniques for Assessing Multivariate Similarity to Address Small-Sample Size ChallengesJohn Heine, Erin Fowler, Steven Eschrich, et al.
The Biochemical Journal|August 8, 2008
Do mammals make all their own inositol hexakisphosphate?Andrew J Letcher, Michael J Schell, Robin F Irvine
Methods in Molecular Biology (Clifton, N.J.)|July 21, 2010
A femtomole-sensitivity mass assay for inositol hexakisphosphateAndrew J Letcher, Michael J Schell, Robin F Irvine
Cancer|October 23, 2004
Recall and detection rates in screening mammographyBonnie C Yankaskas, Michael J Schell, Diana L Miglioretti
Pageof 16

Showing results (11-20 of 156) with videos related to

Sort By:
Pageof 16
Biometrics|July 14, 2005
Continuous toxicity monitoring in phase II trials in oncologyAnastasia Ivanova, Bahjat F Qaqish, Michael J Schell
The Biochemical Journal|June 29, 2005
Agonist-induced regulation of mitochondrial and endoplasmic reticulum motilityDavid Brough, Michael J Schell, Robin F Irvine
JAMA|October 11, 2022
Physician Adenoma Detection Rates and Colorectal CancerMichael J Schell, Clement K Gwede, Mark Friedman
JAMA Network Open|March 10, 2020
Assessment of Treatment Cost-effectiveness Using a Colorectal Cancer Mutation ProfileTimothy J Yeatman, Michael J Schell, William Sause
Plos One|October 22, 2009
Analysis of group randomized trials with multiple binary endpoints and small number of groupsJi-Hyun Lee, Michael J Schell, Richard Roetzheim
Cancer Control : Journal of the Moffitt Cancer Center|December 17, 2009
The false discovery rate: a key concept in large-scale genetic studiesJames J Chen, Paula K Roberson, Michael J Schell
Biorxiv : the Preprint Server for Biology|May 18, 2026
Synthetic Data Generation and Nonparametric Techniques for Assessing Multivariate Similarity to Address Small-Sample Size ChallengesJohn Heine, Erin Fowler, Steven Eschrich, et al.
The Biochemical Journal|August 8, 2008
Do mammals make all their own inositol hexakisphosphate?Andrew J Letcher, Michael J Schell, Robin F Irvine
Methods in Molecular Biology (Clifton, N.J.)|July 21, 2010
A femtomole-sensitivity mass assay for inositol hexakisphosphateAndrew J Letcher, Michael J Schell, Robin F Irvine
Cancer|October 23, 2004
Recall and detection rates in screening mammographyBonnie C Yankaskas, Michael J Schell, Diana L Miglioretti
Pageof 16